Tomasz Grodzicki Selected Research

Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)

1/2021	What factors influence the long-term survival of nursing home residents with severe disabilities?
1/2021	Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications.
1/2017	Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
1/2015	Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy.
11/2011	Epidemiology and management of coexisting heart failure and atrial fibrillation in an outpatient setting.
1/2003	[Prevention of stroke and vascular dementia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomasz Grodzicki Research Topics

Disease

40	Hypertension (High Blood Pressure) 01/2022 - 01/2002
16	Heart Failure 01/2022 - 01/2004
8	COVID-19 01/2022 - 01/2021
7	Infections 12/2021 - 11/2008
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 08/2009
6	Stroke (Strokes) 09/2021 - 01/2003
6	Atrial Fibrillation 05/2021 - 01/2003
6	Inflammation (Inflammations) 01/2020 - 01/2014
5	Chronic Renal Insufficiency 10/2022 - 01/2014
5	Cognitive Dysfunction 12/2021 - 01/2003
5	Obesity 05/2021 - 12/2016
5	Neoplasms (Cancer) 01/2021 - 01/2018
5	Insulin Resistance 01/2019 - 11/2014
4	Pneumonia (Pneumonitis) 11/2021 - 01/2013
4	Malnutrition (Nutritional Deficiencies) 01/2020 - 01/2013
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2021 - 01/2012
3	Overweight 01/2021 - 01/2013
3	Dementia (Dementias) 01/2021 - 01/2003
3	Frailty 01/2021 - 07/2012
3	Heart Diseases (Heart Disease) 01/2020 - 08/2009
3	Mood Disorders (Mood Disorder) 04/2019 - 09/2014
3	Atherosclerosis 09/2017 - 08/2006
3	Delirium 01/2017 - 01/2009
3	Essential Hypertension 01/2015 - 01/2011
3	Hypercholesterolemia 01/2014 - 01/2011
2	Asthma (Bronchial Asthma) 09/2021 - 01/2012
2	Thyroid Diseases (Thyroid Disease) 05/2021 - 01/2021
2	Chronic Disease (Chronic Diseases) 01/2021 - 01/2012
2	Pain (Aches) 04/2019 - 08/2017
2	Vitamin D Deficiency 01/2018 - 01/2012
2	Vascular Calcification 01/2014 - 12/2006
2	Rheumatoid Arthritis 01/2013 - 05/2012
2	Myocardial Infarction 01/2012 - 08/2005
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Liver Diseases (Liver Disease) 11/2021
1	Dyspnea (Shortness of Breath) 11/2021
1	Hypokalemia 10/2021
1	Transient Ischemic Attack 05/2021
1	Ischemic Stroke 05/2021
1	Coronary Disease (Coronary Heart Disease) 05/2021
1	Alzheimer Disease (Alzheimer's Disease) 04/2021
1	Prostatic Neoplasms (Prostate Cancer) 04/2021

Drug/Important Bio-Agent (IBA)

14	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2003
8	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2014
8	C-Reactive ProteinIBA 09/2021 - 01/2015
7	SodiumIBA 01/2021 - 12/2004
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2003
5	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2017
4	Cardiovascular AgentsIBA 01/2022 - 01/2021
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2003
4	Insulin (Novolin)FDA Link 01/2017 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 10/2022 - 12/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2016
3	Vitamin D FDA LinkGeneric 01/2021 - 01/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 08/2005
3	SaltsIBA 01/2019 - 08/2004
3	Nicotinamide PhosphoribosyltransferaseIBA 12/2016 - 11/2014
3	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2015 - 08/2004
3	CreatinineIBA 01/2015 - 01/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2013
2	AdipokinesIBA 11/2021 - 01/2017
2	Ferritins (Ferritin)IBA 11/2021 - 01/2021
2	PotassiumIBA 10/2021 - 12/2011
2	ElectrolytesIBA 10/2021 - 01/2009
2	DiureticsIBA 10/2021 - 01/2021
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 09/2021 - 01/2021
2	Syntex adjuvant formulationIBA 05/2021 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2015
2	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 12/2004
2	OsteoprotegerinIBA 01/2020 - 01/2015
2	N 30IBA 11/2019 - 01/2002
2	Triglycerides (Triacylglycerol)IBA 05/2019 - 01/2002
2	LithiumIBA 01/2019 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 11/2018 - 01/2017
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2018 - 01/2017
2	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 09/2010
2	LipidsIBA 12/2016 - 08/2005
2	Hormones (Hormone)IBA 12/2015 - 01/2004
2	CholesterolIBA 01/2003 - 01/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	LaxativesIBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 04/2021

Therapy/Procedure

23	Therapeutics 01/2021 - 01/2003
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
7	Activities of Daily Living (ADL) 09/2021 - 08/2014
4	Long-Term Care 01/2021 - 01/2013
4	Secondary Prevention 08/2018 - 01/2003
4	Home Nursing (Nursing, Home) 01/2018 - 07/2012
3	Polypharmacy 01/2021 - 01/2013
2	Radiotherapy 01/2021 - 11/2019
2	Length of Stay 01/2021 - 01/2017
2	Bariatric Surgery 01/2020 - 01/2019
2	Palliative Care (Palliative Therapy) 01/2020 - 01/2020
2	Peritoneal Dialysis 01/2014 - 12/2006
2	Critical Care (Surgical Intensive Care) 09/2010 - 01/2008
1	Patient Isolation 12/2021